Table II. Phenotype of cDCs and pDCs in... | Rockefeller University Press

Table II.

Phenotype of cDCs and pDCs in pancreatic LNs from LCMV-infected Vα14 Ins-NP mice

Cell surface marker	cDCs (CD11c⁺120G8⁻)			pDCs (CD11c⁺120G8⁺)
	Day 0	Day 6	Fold change	Day 0	Day 6	Fold change
CD80	255 ± 20	462 ± 11^a	1.81	204 ± 36	405 ± 18^a	1.98
CD86	325 ± 33	543 ± 18^a	1.67	285 ± 19	475 ± 31^a	1.67
CD40	240 ± 18	470 ± 41^a	1.95	125 ± 12	350 ± 20^a	2.80
I-Ag7 (MHC class II)	824 ± 45	1,180 ± 37^a	1.43	201 ± 43	274 ± 51^a	1.36
PD-L1	582 ± 23	1,056 ± 27^a	1.81	219 ± 25	738 ± 35^a	3.37

Cell surface marker	cDCs (CD11c⁺120G8⁻)			pDCs (CD11c⁺120G8⁺)
	Day 0	Day 6	Fold change	Day 0	Day 6	Fold change
CD80	255 ± 20	462 ± 11^a	1.81	204 ± 36	405 ± 18^a	1.98
CD86	325 ± 33	543 ± 18^a	1.67	285 ± 19	475 ± 31^a	1.67
CD40	240 ± 18	470 ± 41^a	1.95	125 ± 12	350 ± 20^a	2.80
I-Ag7 (MHC class II)	824 ± 45	1,180 ± 37^a	1.43	201 ± 43	274 ± 51^a	1.36
PD-L1	582 ± 23	1,056 ± 27^a	1.81	219 ± 25	738 ± 35^a	3.37

MFI was assessed on DC subsets in pancreatic LNs of Ins-NP Vα14 mice before and 6 d after LCMV infection. Results correspond to means ± SD of values obtained in four independent experiments with three pooled mice per group.

P < 0.05 for day 6 compared with day 0.

[ViewLarge]